Literature DB >> 16186301

Diabetes during diarrhea-associated hemolytic uremic syndrome: a systematic review and meta-analysis.

Rita S Suri1, William F Clark, Nick Barrowman, Jeffrey L Mahon, Heather R Thiessen-Philbrook, M Patricia Rosas-Arellano, Kelly Zarnke, Jocelyn S Garland, Amit X Garg.   

Abstract

OBJECTIVE: To quantify the incidence of diabetes during the acute phase of diarrhea-associated hemolytic uremic syndrome (D + HUS) and to identify features associated with its development. RESEARCH DESIGN AND METHODS: A systematic review and meta-analysis of articles assessing diabetes during D + HUS was conducted. Relevant citations were identified from Medline, Embase, and Institute for Scientific Information Citation Index databases. Bibliographies of relevant articles were hand searched. All articles were independently reviewed for inclusion and data abstraction by two authors.
RESULTS: Twenty-one studies from six countries were included. Only 2 studies reported a standard definition of diabetes; 14 defined diabetes as hyperglycemia requiring insulin. The incidence of diabetes during the acute phase of D + HUS could be quantified in a subset of 1,139 children from 13 studies (1966-1998, age 0.2-16 years) and ranged from 0 to 15%, with a pooled incidence of 3.2% (95% CI 1.3-5.1, random-effects model, significant heterogeneity among studies, P = 0.007). Children who developed diabetes were more likely to have severe disease (e.g., presence of coma or seizures, need for dialysis) and had higher mortality than those without diabetes. Twenty-three percent of those who developed diabetes acutely died, and 38% of survivors required long-term insulin (median follow-up 12 months). Recurrence of diabetes was possible up to 60 months after initial recovery.
CONCLUSIONS: Children with D + HUS should be observed for diabetes during their acute illness. Consideration should be given to long-term screening of D + HUS survivors for diabetes.

Entities:  

Mesh:

Year:  2005        PMID: 16186301     DOI: 10.2337/diacare.28.10.2556

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  15 in total

Review 1.  Guidelines for the management and investigation of hemolytic uremic syndrome.

Authors:  Takashi Igarashi; Shuichi Ito; Mayumi Sako; Akihiko Saitoh; Hiroshi Hataya; Masashi Mizuguchi; Tsuneo Morishima; Kenji Ohnishi; Naohisa Kawamura; Hirotsugu Kitayama; Akira Ashida; Shinya Kaname; Hiromichi Taneichi; Julian Tang; Makoto Ohnishi
Journal:  Clin Exp Nephrol       Date:  2014-08       Impact factor: 2.801

2.  C3 levels and acute outcomes in Shiga toxin-related hemolytic uremic syndrome.

Authors:  Alejandro Balestracci; Luciana Meni Bataglia; Ismael Toledo; Laura Beaudoin; Caupolican Alvarado
Journal:  Pediatr Nephrol       Date:  2019-09-02       Impact factor: 3.714

3.  Childhood hemolytic uremic syndrome is associated with adolescent-onset diabetes mellitus.

Authors:  J Darrell Nesmith; Eileen Ellis
Journal:  Pediatr Nephrol       Date:  2006-09-08       Impact factor: 3.714

4.  Pharmacogenetics of post-transplant diabetes mellitus in children with renal transplantation treated with tacrolimus.

Authors:  Pauline Lancia; Tiphaine Adam de Beaumais; Valéry Elie; Florentine Garaix; Marc Fila; François Nobili; Bruno Ranchin; Pascale Testevuide; Tim Ulinski; Wei Zhao; Georges Deschênes; Evelyne Jacqz-Aigrain
Journal:  Pediatr Nephrol       Date:  2018-02-04       Impact factor: 3.714

Review 5.  Long-term outcomes of Shiga toxin hemolytic uremic syndrome.

Authors:  Joann M Spinale; Rebecca L Ruebner; Lawrence Copelovitch; Bernard S Kaplan
Journal:  Pediatr Nephrol       Date:  2013-01-04       Impact factor: 3.714

Review 6.  New-onset diabetes after kidney transplant in children.

Authors:  Rouba Garro; Barry Warshaw; Eric Felner
Journal:  Pediatr Nephrol       Date:  2014-06-04       Impact factor: 3.714

7.  Extrarenal manifestations of the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli (STEC HUS).

Authors:  Myda Khalid; Sharon Andreoli
Journal:  Pediatr Nephrol       Date:  2018-11-01       Impact factor: 3.714

Review 8.  Shiga Toxin-Associated Hemolytic Uremic Syndrome: Specificities of Adult Patients and Implications for Critical Care Management.

Authors:  Benoit Travert; Cédric Rafat; Patricia Mariani; Aurélie Cointe; Antoine Dossier; Paul Coppo; Adrien Joseph
Journal:  Toxins (Basel)       Date:  2021-04-26       Impact factor: 4.546

9.  Clinical aspects of a nationwide epidemic of severe haemolytic uremic syndrome (HUS) in children.

Authors:  Lars Krogvold; Thore Henrichsen; Anna Bjerre; Damien Brackman; Henrik Dollner; Helga Gudmundsdottir; Gaute Syversen; Pål Aksel Næss; Hans Jacob Bangstad
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2011-07-28       Impact factor: 2.953

10.  Outbreak of Escherichia coli and diabetes mellitus.

Authors:  Viroj Wiwanitkit
Journal:  Indian J Endocrinol Metab       Date:  2011-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.